Emergent BioSolutions
EBS
#8033
Rank
A$0.53 B
Marketcap
A$10.28
Share price
-0.55%
Change (1 day)
18.27%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): A$88.44 Million

According to Emergent BioSolutions 's latest financial reports the company's current earnings are A$0.64 Billion. In 2025 the company made an earning of A$0.20 Billion, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$88.44 M-56.27%
2025 A$0.20 B-297.64%
2024 -A$0.11 Billion-88.82%
2023 -A$0.92 Billion242.73%
2022 -A$0.27 Billion-153.8%
2021 A$0.49 B-20.43%
2020 A$0.62 B278.02%
2019 A$0.16 B27.11%
2018 A$0.12 B-27.12%
2017 A$0.17 B17.21%
2016 A$0.15 B0.45%
2015 A$0.15 B73.51%
2014 A$87.25 M41.36%
2013 A$61.72 M35.2%
2012 A$45.65 M0.4%
2011 A$45.47 M-56.46%
2010 A$0.10 B76.73%
2009 A$59.09 M32.94%
2008 A$44.45 M-5.62%
2007 A$47.1 M
2005 A$68.19 M269.89%
2004 A$18.43 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.07 B 17,820.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.72 B 22,153.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.25 B 16,839.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$16.66 Million-119.80%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
A$29.37 M-65.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.44 Billion-622.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.23 B 3,742.64%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel